•  
  •  
  •  
  •  

2025-10-04 10:48:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand

Keywords Selected:  Research

Research

  • Landmark Cars - IPO - Landmark for Premium Cars - Reliance Research
  • Top 8 Cities See 68 Land Deals for 1,656+ Acres in 9M 2022 - ANAROCK
  • Reliance Research - Bajaj Auto - 2QFY23 Result Update - Strong Performance; Upgrade to BUY on Attractive Valuation
  • Acuité Ratings & Research comments on WPI - Aug'22
  • New global research from Mastercard reveals Indian consumers' payment preferences
  • Profitability of domestic broking companies moderates after a strong FY2022: ICRA
  • Comments on CPI inflation - Jun'22 - Acuité Ratings & Research
  • Reliance Research downgrades Bajaj Auto to Sell
  • India IT Services - Results Preview - Seasonally weak quarter; Supply Side Issue to Continue Exerting Margin Pressure
  • Acuité's forecast currently stands at 5.0% for FY23 - CPI Feb-22
  • Indian Aviation - 2022: A year of two halves - HSBC
  • HP Adhesive - IPO - Adhesive Play at Stretched Valuation - Reliance Research
  • Medplus Healthcare Services - IPO - Healthcare Retailer on Expansion Mode; Attractive Valuation - Reliance Research
  • India's GDP back to its pre-Covid levels - Acuite Ratings & Research
  • Mphasis - 2QFY22 Result Update - Growth Resiliency Continues; Raise Target Price - Reliance Research
  • Mphasis - 2QFY22 Result Update - Growth Resiliency Continues; Raise Target Price - Reliance Research
  • Indraprastha Gas - Company Update - EV vs CNG; TCO Economics Favour CNG - Reliance Research
  • Havells India - 2QFY22 Result Update - Strong Revenue Growth; Higher Commodity Prices Impact Earnings - Reliance Research
  • TVS Motor - 2QFY22 Result Update - Healthy Exports Coupled with New Launches to Aid Higher Margins - Reliance Research
  • At 11-year high, BSE Realty Index still lower than 2008 peak
  • Wipro - 2QFY22 Result Update - Continued Growth Outperformance; Raise TP to Rs760 - Reliance Research
  • Mid-caps - Q2FY22 Results Preview - Healthy YoY Growth Across Segments - Reliance Research
  • Cement & Building Materials - Results Preview - Cost Inflations to Weigh on Performance - Reliance Research
  • Oil & Gas, Chemical & Telecom Sector - Results Preview - On Growth Trajectory - Reliance Research

Market Commentary

  • RBI MPC - Acuité Ratings & Research comments on RBI MPC - Apr'23

IPO News

  • TCS Ranks No. 1 in Customer Satisfaction in France for 5th year
  • CX Partners-backed Veeda Clinical Research gets Sebi nod for its Rs 832 crore IPO

Stock Report

  • Indegene announces acquisition of BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma
  • Payments industry races toward AI-driven future, but lacks guardrails and confidence, according to new HCLTech report
  • Datavant and Indegene Partner to Power More Efficient Clinical Trial Recruitment
  • Indegene Expands India Footprint, Opens New Center in Pune
  • Indegene Wins Gold for Gamified Learning and Development Approach at Brandon Hall Group's HCM Excellence Awards 2025
  • Indegene Launches NEXT Medical Writing Automation to Streamline Complex Medical Writing Workflows with GenAI
  • Indegene Identified as a Leader in ISG's Provider Lens™ Evaluation for Life Sciences Digital Services in Commercial Operations - Digital Evolution (Service Providers) Quadrant 2025
  • Hexaware Ranked #1 in Overall Client Satisfaction in Whitelane UK & Ireland IT Sourcing Study 2025
  • HCLTech study underscores the criticality of product-aligned operating models to drive innovation, efficiency and customer value
  • Ind-Ra upgrades rating of debt facilities of JSW Renew Energy Two Limited
  • The Indian School of Public Policy and Indegene announce strategic collaboration
  • Indegene Limited recommends final dividend of Rs. 2
  • Indian pvt banks occupy more broadcast media space though SBI pips them to occupy top slot
  • Coforge and HFS Research Unveil Blueprint for Enterprises to Scale on GenAI
  • Indegene expands presence in Europe, announces New Center in London
  • Financial Times Names Indegene Among High-Growth Companies in AsiaPacific 2025
  • Deloitte Names Indegene a Winner of Enterprise Growth Awards 2025
  • Indegene Launches Cortex, A Fit-For-Purpose Generative AI Platform, Verticalized For The Life Sciences Industry
  • Indegene Wins 2025 BIG Innovation Award for Hyper-Automated AI Solution
  • Indegene recognized among Top 50 Companies with Great Managers in the Great Manager Awards 2024 by People Business
  • Indegene Wins Deloitte Technology Fast 50 India 2024 Award in HealthTech
  • Indegene Ranked Among Top 100 Companies for Women to Work in India by AVTAR
  • Indegene Awarded Silver Medal, Scores 72/100 in ESG Assessment by EcoVadis
  • Indegene expands Global Delivery Network, announces a New Center in Hyderabad

Mutual Funds

  • ESGrisk.ai Launches ESG Mutual Funds Research

Latest Post

  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024